18+ • For Research & Educational Purposes Only • Not Medical Advice  Disclaimer
Peptide Wiki
Skin & AestheticsCommunity

Matrixyl

The most clinically studied topical anti-aging peptide, directly stimulating collagen I, III, and IV synthesis in the dermis

Research Reality Check

Commonly MisunderstoodPeople often stretch this claim too far.
ClaimSome people claim Matrixyl has clear value for skin & aesthetics research.
RealityCommunity interest is high, but popularity is not proof.
Bottom LineUse the evidence score, sources, and safety notes before taking any claim seriously.
Why People Believe ThisSimple explanations and user stories can sound more certain than the research is.
Watch Out For
Guaranteed resultsExact protocols presented as provenAnecdotes used as proof
612Discussions
2Citations

Evidence Dossier

89Evidence

Community

Evidence score reflects source depth, citations, and research maturity. It is not a medical recommendation.

2Citations
612Discussions
Start Here

Matrixyl at a glance

A fast read for beginners, with evidence strength, route context, safety depth, and community activity surfaced before the deeper sections.

Evidence score89Community-led
Primary routeMatrixyl 3% to 8% Concentration SolutionRoute availability varies by context
Safety depthModerate dataReview safety notes before making assumptions
Community questions612Related discussions and experiences

Matrixyl (Palmitoyl Pentapeptide-4, Pal-KTTKS) is a lipopeptide developed by Sederma in the 1990s, produced by coupling a fatty acid (palmitic acid) to the lysine-threonine-threonine-lysine-serine (KTTKS) sequence - a fragment of the pro-collagen I alpha chain that acts as a matrikine signaling molecule. When collagen degrades, KTTKS is released as a matrikine, signaling dermal fibroblasts to synthesize new collagen. Matrixyl mimics this signal.

How It Works

Clinical studies have demonstrated statistically significant increases in collagen I, III, and IV synthesis, fibronectin production, and hyaluronic acid levels in fibroblast cell culture, accompanied by measurable wrinkle depth reductions of 20-35% in human trials. A 2005 randomized controlled trial showed Matrixyl outperformed vitamin C serum for wrinkle reduction at comparable concentrations.

Matrixyl 3000 (a combination of Palmitoyl Tetrapeptide-7 and Palmitoyl Oligopeptide) and Matrixyl Synthe'6 (targeting 6 key skin proteins) are advanced generations of the same concept with enhanced efficacy data. Matrixyl is the benchmark against which most cosmeceutical peptides are compared.

Key Benefits

✓
Collagen I, III, IV synthesis stimulation
✓
Wrinkle depth reduction
✓
Fibronectin and hyaluronic acid upregulation
✓
Skin firmness improvement
✓
Synergistic with Argireline

Saves this peptide to your Watchlist and helps you find new research, news, and questions later.

Quick Dosing Reference
Dose Range3% to 8% concentration
Frequencyonce or twice daily
RouteMatrixyl 3% to 8% Concentration Solution
Experience LevelBeginner